About Athyrium Capital Management
Athyrium Capital Management is a private equity firm founded in 2008. It is primarily based in New York City, United States. In the last 12 months, it has participated in 2 funding rounds.
Overall Athyrium Capital Management portfolio has seen 1 unicorn, 33 IPOs and 46 acquisitions including key companies like BridgeBio, PTC Therapeutics and Clover Health. A lot of funds co-invest with Athyrium Capital Management, with names like Highbridge sharing a substantial percentage of its portfolio.
Athyrium Capital Management has a team of 20 people, including 5 partners.
Key Metrics
Athyrium Capital Management's Portfolio
They have invested in a total of 105 companies. Their most recent investment was in Hansa Biopharma (Post IPO round) on Mar 20, 2026. Here is the most recent investment by Athyrium Capital Management:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Mar 20, 2026 | Post IPO | 3464 | - | |
Jan 05, 2026 | Series A | 2939 | ||
Jan 10, 2024 | Series A | 1140 | and 5 others | |
Dec 18, 2023 | Post IPO | 6695 |
_1574657156572.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Here is the portfolio snapshot of Athyrium Capital Management:
Investments by Year
The maximum number of investments were made in 2019
Team profile of Athyrium Capital Management
Athyrium Capital Management has a team of 20 members including 5 Partners and 4 Principals located in United States, India and 1 more location. Athyrium Capital Management's team does not sit on the board of any company as of now.Here is a list of top team members in Athyrium Capital Management:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York City | - | - | |
Partner | New York City | - | - | |
Partner | New York City | - | - | |
Partner | New York City | - | - | |
Partner | New York | - | - | |
Principal | New York City | - | - | |
Principal | New York City | - | - | |
Principal | New York City | - | ||
Principal | New York | - | - | |
Advisor | Boston | - | - | |
Advisor | India | - |
Co-investors of Athyrium Capital Management
Over the past 18 years, 24 investors have co-invested in Athyrium Capital Management's portfolio companies.
- Top Co-investors of Athyrium Capital Management: 24 investors entered a company along with Athyrium Capital Management. These include investors like Highbridge (3 companies).
Athyrium Capital Management News
•
Hansa Biopharma Announces USD 30 Million Convertible Note FinancingCision•Mar 20, 2026•Hansa Biopharma, Athyrium Capital Management
•
SBC Medical Expands Globally with Investment in US MedSpa OrangeTwistBusinessFortNight•Jan 05, 2026•Athyrium Capital Management, SBC Medical Group Holdings, OrangeTwist, Hildred Capital Management
•
Four investors sell their stake in Pharmaceutics International.Business Wire•Feb 06, 2025•Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital Management, PharmaScience and 2 others
•
PE-led investor group sells Pharmaceutics International to JabilPE Hub•Feb 06, 2025•Pharmaceutics International, Signet Healthcare Partners, Athyrium Capital Management, Hildred and 2 others
•
Esperion Strengthens Balance Sheet with Closing of Significant Refinancing TransactionsGlobeNewswire•Dec 18, 2024•Esperion Therapeutics, Athyrium Capital Management
•
Esperion Announces $210 Million Convertible Debt FinancingGlobeNewswire•Dec 13, 2024•Esperion Therapeutics, J. Wood Capital Advisors, Athyrium Capital Management, HCRx
•
Suicide prevention telehealth provider Vita Health receives $22.5MMobiHealthNews•Jan 10, 2024•Vita Health, LFE Capital, CVS Health, Athyrium Capital Management and 4 others
•
Athyrium Capital Management Provides $102.3MM Term Loan to CalliditasABFJournal•Dec 28, 2023•Calliditas Therapeutics, Athyrium Capital Management, Kreos Capital
•
Calliditas refinances existing term loan with Euro 92 million senior secured facility with Athyrium CapitalPR Newswire•Dec 27, 2023•Calliditas Therapeutics, Athyrium Capital Management, Kreos Capital
•
Calliditas Refinances Existing Term Loan With Euro 92 Million Senior Secured Facility With Athyrium CapitalSharecast•Dec 27, 2023•Calliditas Therapeutics, Athyrium Capital Management
